TREM2 and Brain atrophy: On the other hand, Sayed et al. [59] showed that TREM2 haploinsufficiency in the PS19 model confers increased brain atrophy, exaggerated tau pathology, and an increase in proinflammatory markers suggesting a dose-dependent response of TREM2 in PS19 mice.